Koye Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 2013.
2013 Mumbai, Maharashtra, India Active
Last Updated:
About Koye Pharmaceuticals Private Limited

Koye Pharmaceuticals Private Limited, a active private limited company, was established on 12 May 2013 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U74120MH2013PTC243214. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹46.01 Cr and a paid-up capital of ₹21.58 Cr.

It upholds a compliant status. Employing 673 professional, Its leadership includes Ravindra Yogesh Shenoy (Director), Preetish Mohan Toraskar (Director), Vishal Kaushik (Director). Past directors included Ravindra Yogesh Shenoy, Nikhil Tambolkar, Anjana Sasidharan. It holds ₹101.45 Cr open charges and ₹149.76 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Sf A-01, Art Guild House, Phoenix Market City Annexe,, Lbs Marg, Kurla (West), Mumbai, Mumbai, Maharashtra, 400070.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74120MH2013PTC243214

  • Registration Number

    243214

  • Incorporation Date

    12 May 2013

  • Authorized Capital

    ₹46.01 Cr

  • Paid-Up Capital

    ₹21.58 Cr

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 46.01 Cr
  • Paid Up Capital ₹ 21.58 Cr
  • Company Age 12 Year, 9 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 101.45 Cr
  • Satisfied Charges ₹ 149.76 Cr
  • Revenue Growth **** -9.81%
  • Profit Growth **** -346.88%
  • Ebitda **** -565.48%
  • Net Worth -387.60%
  • Total Assets -8.79%
Company report

Koye Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Koye Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Koye Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Ravindra Yogesh Shenoy Director 16 Jul 2013 Current
Preetish Mohan Toraskar Director 09 Sep 2013 Current
Vishal Kaushik Director 27 Aug 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Managing Director 31 Jul 2013 Past
Pramod Abcsdd Nominee Director 30 Sep 2024 Past
Pramod Abcsdd Nominee Director 23 Mar 2020 Past
Pramod Abcsdd Nominee Director 11 Sep 2018 Past
Pramod Abcsdd Additional Director 26 Sep 2014 Past
Pramod Abcsdd Nominee Director 13 Oct 2023 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Koye Pharmaceuticals.

Koye Pharmaceuticals Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 9.81% decrease. The company also saw a substantial fall in profitability, with a 346.88% decrease in profit. The company's net worth observed a substantial decline by a decrease of 387.6%.

Koye Pharmaceuticals revenue growth over time
Koye Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
-9.81%
*******
*******
*******
*******
Revenue from Operations
*******
-11.75%
*******
*******
*******
*******
Total Assets
*******
-8.79%
*******
*******
*******
*******
Profit or Loss
*******
-346.88%
*******
*******
*******
*******
Net Worth
*******
-387.60%
*******
*******
*******
*******
EBITDA
*******
-565.48%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Koye Pharmaceuticals?

In 2023, Koye Pharmaceuticals had a promoter holding of 99.90% and a public holding of 0.10%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹1,014,500,000.00

Satisfied Charges

₹1,497,605,000.00

Charges Breakdown by Lending Institutions
  • Others : 56.85 Cr
  • Axis Bank Limited : 41.60 Cr
  • Tjsb Sahakari Bank Limited : 3.00 Cr
Latest Charge Details
Date Lender Amount Status
27 Feb 2023 Others ₹20.00 Cr Open
22 Mar 2022 Others ₹36.85 Cr Open
14 Jan 2022 Tjsb Sahakari Bank Limited ₹3.00 Cr Open
26 Oct 2021 Axis Bank Limited ₹15.00 Cr Open
18 May 2021 Axis Bank Limited ₹26.60 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Koye Pharmaceuticals?

Koye Pharmaceuticals has a workforce of 673 employees as of Jan 23, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Koye Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Koye Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Koye Pharmaceuticals
Recent Activity within the Organization
  • Director Appointment

    Progress on Vishal Kaushik was appointed as a Director was appointed as a Director on 27 Aug 2025 & has been associated with this company since 6 months 6 days . was documented.

  • Charges

    The activity A charge registered on 22 Feb 2022 via Charge ID 100551519 with Yes Bank Limited was fully satisfied on 17 Apr 2025. was completed.

  • Charges

    The activity A charge registered on 25 Jun 2021 via Charge ID 100501394 with Yes Bank Limited was fully satisfied on 17 Apr 2025. was completed.

  • Director Appointment

    Juhi Gurnani was appointed as a Company Secretary was appointed as a Company Secretary on 25 Mar 2025 & has been associated with this company since 11 months 8 days . was recorded as a recent event.

  • Annual General Meeting

    Progress on Koye Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.

  • Charges

    Progress on A charge registered on 17 Mar 2022 via Charge ID 100558857 with Others was fully satisfied on 02 Sep 2024. was documented.

Explore recent activity and updates - View Recent Activity

Recent News, Updates & Announcement

Explore news and more updates - View Recent News

Frequently Asked Questions
What is the CIN of Koye Pharmaceuticals Private Limited?

The CIN of Koye Pharmaceuticals Private Limited is U74120MH2013PTC243214.

Where is Koye Pharmaceuticals Private Limited headquartered?

Koye Pharmaceuticals Private Limited is headquartered at Sf A-01, Art Guild House, Phoenix Market City Annexe,, Lbs Marg, Kurla (West), Mumbai, Mumbai, Maharashtra, 400070.

When was Koye Pharmaceuticals Private Limited incorporated?

Koye Pharmaceuticals Private Limited was incorporated on 12 May 2013.

Who are the current directors of Koye Pharmaceuticals Private Limited?

The current directors of Koye Pharmaceuticals Private Limited are

What is the primary industry of Koye Pharmaceuticals Private Limited?

The primary industry of Koye Pharmaceuticals Private Limited is Manufacturing.

Is Koye Pharmaceuticals Private Limited a listed company?

Koye Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Koye Pharmaceuticals Private Limited?

The authorized capital of Koye Pharmaceuticals Private Limited is ₹46.01 Cr, and the paid-up capital is ₹21.58 Cr.

What is the compliance status of Koye Pharmaceuticals Private Limited?

The compliance status of Koye Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available